Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

This association was independent of age, BMI, alcohol use, HIV and HCV status, and vitamin D.

Source: Association of Methadone Use and Bone Mineral Density. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This is a cross-sectional study nested within the AIDS Linked to the IntraVenous Experience (ALIVE) cohort.

Source: Methods.

Menopausal status for women was assessed based on self-report and the date of last menstrual cycle (menopause was assigned if last menstrual cycle was > 12 months earlier).

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Methadone Maintenance Treatment, Sex Hormones, and Bone Mineral Density in Persons Who Inject Drugs

Cross-sectional study · Journal of the Endocrine Society · 2025

Original publication title

Methadone Maintenance Treatment, Sex Hormones, and Bone Mineral Density in Persons Who Inject Drugs

Leen Wehbeh; Hsing-yu Hsu; Jenny Pena Dias; Kendall F Moseley; Susan Langan; Yutong Jiang; Damani A Piggott; Gregory D Kirk; Adrian S Dobs; Todd T Brown; Jing Sun

© The Author(s) 2025. Published by Oxford University Press on behalf of the Endocrine Society.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Among men who inject drugs, MMT may contribute to decreased BMD, potentially through decreased levels of free T and total E2.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

This work aimed to assess the relationships among bone mineral density (BMD) T-score, sex hormones, and MMT among individuals who inject drugs.

Source: Objective

Abstract: What methods does the paper describe?

We included study participants from the AIDS Linked to the Intravenous Experience (ALIVE) cohort. We performed multivariable linear regression to assess the association of MMT with BMD T-scores (lumbar spine, total hip, and femoral neck) in men and women. We further assessed whether sex hormones estradiol (E2) and free testosterone (free T) influenced the association between MMT and BMD in men and women. We controlled for age, sex, body mass index, smoking and heavy alcohol use (≥3 times per week), HIV status and/or hepatitis C virus viremia, vitamin D level, and heroin use.

Source: Methods

Abstract: Context

Methadone maintenance treatment (MMT) has been used to treat opioid use disorder, but is associated with bone loss. Sex hormones may mediate this relationship, though studies are limited.

Source: Context

Abstract: Results

Among 245 participants (153 men; 92 women), 107 were receiving MMT. Men undergoing MMT were more likely to have a low free T level compared to men not receiving MMT (odds ratio, 3.99; 95% CI, 1.40-11.39; P = .010). No significant differences in the odds of menopause in women by MMT status were observed. Individuals on MMT had significantly lower lumbar spine T-scores (β: −.55; 95% CI, −1.06 to −.05), independent of covariates. After adjusting for E2 and/or free T, the association between MMT and BMD was not significant, suggesting potential mediation.

Source: Results

Abstract: Conclusion

Among men who inject drugs, MMT may contribute to decreased BMD, potentially through decreased levels of free T and total E2.

Source: Conclusion
Authors’ abstract

Abstract

Context

Methadone maintenance treatment (MMT) has been used to treat opioid use disorder, but is associated with bone loss. Sex hormones may mediate this relationship, though studies are limited.

Objective

This work aimed to assess the relationships among bone mineral density (BMD) T-score, sex hormones, and MMT among individuals who inject drugs.

Methods

We included study participants from the AIDS Linked to the Intravenous Experience (ALIVE) cohort. We performed multivariable linear regression to assess the association of MMT with BMD T-scores (lumbar spine, total hip, and femoral neck) in men and women. We further assessed whether sex hormones estradiol (E2) and free testosterone (free T) influenced the association between MMT and BMD in men and women. We controlled for age, sex, body mass index, smoking and heavy alcohol use (≥3 times per week), HIV status and/or hepatitis C virus viremia, vitamin D level, and heroin use.

Results

Among 245 participants (153 men; 92 women), 107 were receiving MMT. Men undergoing MMT were more likely to have a low free T level compared to men not receiving MMT (odds ratio, 3.99; 95% CI, 1.40-11.39; P = .010). No significant differences in the odds of menopause in women by MMT status were observed. Individuals on MMT had significantly lower lumbar spine T-scores (β: −.55; 95% CI, −1.06 to −.05), independent of covariates. After adjusting for E2 and/or free T, the association between MMT and BMD was not significant, suggesting potential mediation.

Conclusion

Among men who inject drugs, MMT may contribute to decreased BMD, potentially through decreased levels of free T and total E2.

Publication and source details

Original title: Methadone Maintenance Treatment, Sex Hormones, and Bone Mineral Density in Persons Who Inject Drugs

Leen Wehbeh; Hsing-yu Hsu; Jenny Pena Dias; Kendall F Moseley; Susan Langan; Yutong Jiang; Damani A Piggott; Gregory D Kirk; Adrian S Dobs; Todd T Brown; Jing Sun

Journal of the Endocrine Society · 2025

Correspondence: Todd T. Brown, MD, PhD, Medicine and Epidemiology, Division of Endocrinology, Diabetes, and Metabolism, Johns Hopkins University, 1830 E Monument St, Ste 333, Baltimore, MD 21287, USA. Email: tbrown27@jhmi.edu.

Leen Wehbeh and Hsing-yu Hsu joint first authors.

Todd T Brown and Jing Sun joint senior authors.

© The Author(s) 2025. Published by Oxford University Press on behalf of the Endocrine Society.2025https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. See the journal About page for additional terms. National Institute on Drug Abuse10.13039/100000026 K01AI162247R01-DA04334U01-DA036297R01-DA048063 Johns Hopkins Institute for Clinical and Translational Research National Institutes of Health10.13039/100000002 National Center for Advancing Translational Sciences10.13039/100006108 UL1 TR003098

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T00:52:59.750159+00:00

DOI: 10.1210/jendso/bvaf140 · PMC12547197